AXOVANT SCIENCES LTD
COM · CUSIP G0750W104
2
institutional holders
+0 vs Q1 2021
9.0k
shares reported held*
$1.6mreported value*
0 new
1 added
0 reduced
0 sold out
net bought ≈ $53.2k (+301 shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $176.76.
Trends to Q2 2021
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 2 |
| Q1 2020 | 2 |
| Q2 2020 | 1 |
| Q3 2020 | 1 |
| Q4 2020 | 2 |
| Q1 2021 | 2 |
| Q2 2021 | 2 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2020 | 0 | 1 |
| Q2 2020 | 0 | 1 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 1 | 0 |
| Q1 2021 | 1 | 1 |
| Q2 2021 | 1 | 0 |
Biggest buyers
| Tower View Wealth Management LLC | Added | +301 |
Biggest sellers
| None |
Holders, Q2 2021
| Manager | Shares | Change |
|---|---|---|
| Tower View Wealth Management LLC 0.81% of their portfolio | 9.0k $1.6m | Added +301 |
| IFP Advisors, Inc 0.00% of their portfolio | 0 $0 | Unchanged |